Fair comment. However there will come a time when a line needs to be drawn. Nothing alters the fact that a massive amount of capital is required to develop a vaccine / drug.Building a stake in Admedus vaccines is not a positive if it doesn't succeed. We are just financing research.
My belief is the company would thrive without the vaccine.
Previously I have suggested creating a separate company listing for the vaccine. This allows investors to decide whether they want to finance research ,or support a growing company. They also have the opportunity to do both.
AHZ Price at posting:
29.0¢ Sentiment: Hold Disclosure: Held
